ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
4,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
5,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
6,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
7,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
8,2,Headache,Headaches NEC,Headaches,Nerv,N
8,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
8,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
9,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
9,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
10,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
11,1,Hangover,Feelings and sensations NEC,General system disorders NEC,Genrl,N
11,2,Headache,Headaches NEC,Headaches,Nerv,N
11,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
11,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
12,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
13,1,Headache,Headaches NEC,Headaches,Nerv,N
14,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
15,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
16,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
16,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
17,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
17,2,Diabetic retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
18,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
18,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
19,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
20,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
20,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
21,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
22,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
22,2,Hypoglycaemia unawareness,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
22,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
22,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
22,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
23,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
23,2,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,Y
24,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
25,1,Diabetic neuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
25,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
26,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
27,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,Y
28,1,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
28,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
28,3,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
29,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
29,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
29,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
30,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
30,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
30,3,Hypoglycaemia unawareness,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
31,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
32,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
32,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
33,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
33,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
34,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
34,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
35,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
35,2,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
36,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
36,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
37,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
37,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
37,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
37,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
38,1,Adjustment disorder with depressed mood,Adjustment disorders,Adjustment disorders (incl subtypes),Psych,N
38,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
39,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
40,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
40,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
41,1,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
42,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
42,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
42,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
43,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
43,2,Headache,Headaches NEC,Headaches,Nerv,N
43,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
43,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
44,1,Lichen planus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
45,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
46,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
46,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
47,1,Headache,Headaches NEC,Headaches,Nerv,N
47,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
47,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
47,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
48,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
48,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
49,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
49,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
49,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
49,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
50,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
50,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
50,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
51,1,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
52,1,Nipple pain,Breast signs and symptoms,Breast disorders,Repro,N
53,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
53,2,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
54,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
54,2,Nipple pain,Breast signs and symptoms,Breast disorders,Repro,N
55,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
55,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
55,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
55,4,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
56,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
57,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
58,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
59,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
59,2,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
60,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
60,2,Headache,Headaches NEC,Headaches,Nerv,N
60,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
61,1,Device failure,Device issues NEC,Device issues,Prod,N
61,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
62,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
62,2,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
63,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
63,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
64,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
64,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
64,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
65,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
65,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
66,1,Device failure,Device issues NEC,Device issues,Prod,N
67,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
68,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
68,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
68,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
68,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
69,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
69,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
70,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
71,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
71,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
71,3,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
71,4,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
71,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
72,1,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
72,2,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
73,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
74,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
75,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
76,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
76,2,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
76,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
77,1,Headache,Headaches NEC,Headaches,Nerv,N
77,2,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
77,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
77,4,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
77,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
78,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
78,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
78,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
79,1,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
80,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
80,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
81,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
81,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
82,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
83,1,Headache,Headaches NEC,Headaches,Nerv,N
83,2,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
83,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
84,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
84,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
84,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
85,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
85,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
85,3,Orthopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
86,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
86,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
87,1,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
87,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
88,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
88,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
89,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
89,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
89,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
90,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
90,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
90,3,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
90,4,Hypoglycaemic seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
91,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
92,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
92,2,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
92,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
93,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
93,2,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
94,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
95,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
95,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
96,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
96,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
96,3,Ketosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
97,1,Hypoglycaemia unawareness,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
98,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
99,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
100,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
101,1,Conjunctival haemorrhage,Conjunctival and corneal bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
101,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
102,1,Headache,Headaches NEC,Headaches,Nerv,N
102,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
103,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
104,1,Headache,Headaches NEC,Headaches,Nerv,N
105,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
105,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
105,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
106,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
107,1,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
108,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
109,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
109,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
109,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
110,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
111,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
112,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
112,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
112,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
113,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
114,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
115,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
115,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
116,1,Hypoglycaemia unawareness,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
116,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
117,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
117,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
117,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
117,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
117,5,Hypoglycaemia unawareness,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
117,6,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
118,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
118,2,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
118,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
119,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
120,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
121,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
122,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
123,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
124,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
124,2,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
125,1,Ketoacidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
126,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
126,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
126,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
127,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
128,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
128,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
129,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
130,1,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
130,2,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
131,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
132,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
133,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
133,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
134,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
135,1,Headache,Headaches NEC,Headaches,Nerv,N
135,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
136,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
137,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
138,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
139,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
139,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
140,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
141,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
141,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
141,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
141,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
142,1,Headache,Headaches NEC,Headaches,Nerv,N
142,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
143,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
143,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
144,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
145,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
145,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
146,1,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
147,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
147,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
147,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
148,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
149,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
149,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
149,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
150,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
151,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
152,1,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
153,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
153,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
153,3,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
153,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
154,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
155,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
156,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
157,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
157,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
157,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
157,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
157,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
158,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
159,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
160,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
161,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
162,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
163,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
163,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
164,1,Congenital nose malformation,Nasal disorders congenital,Respiratory disorders congenital,Cong,N
164,2,Holoprosencephaly,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
164,3,Microcephaly,Musculoskeletal and connective tissue disorders of skull congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
165,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
166,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
166,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
166,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
167,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
167,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
167,3,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
167,4,Inappropriate affect,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
167,5,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
167,6,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
168,1,Motor neurone disease,Motor neurone diseases,Neuromuscular disorders,Nerv,Y
169,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
170,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
170,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
171,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
172,1,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
173,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
174,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
175,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
175,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
175,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
175,4,Headache,Headaches NEC,Headaches,Nerv,N
175,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
175,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
175,7,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
176,1,Sluggishness,Asthenic conditions,General system disorders NEC,Genrl,N
177,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
177,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
178,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
179,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
180,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
180,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
180,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
181,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
182,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
183,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
183,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
183,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
183,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
184,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
185,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
185,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
185,3,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
186,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
187,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
188,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
189,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
189,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
190,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
191,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
191,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
191,3,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
191,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
191,5,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
192,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
192,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
192,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
193,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
194,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
194,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
195,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
195,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
195,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
196,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
197,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
198,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
198,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
199,1,Congenital oral malformation,Oral cavity disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
200,1,Device failure,Device issues NEC,Device issues,Prod,N
200,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
201,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
201,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
202,1,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
202,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
202,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
202,4,Dissociation,Dissociative states,Dissociative disorders,Psych,N
202,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
202,6,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
202,7,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
202,8,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
202,9,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
202,10,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
202,11,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
203,1,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
203,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
203,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
204,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
204,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
205,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
205,2,Device failure,Device issues NEC,Device issues,Prod,N
206,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
206,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
207,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
207,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
208,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
209,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
209,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
209,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
210,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
210,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
211,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
211,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
211,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
212,1,Dysaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
213,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
214,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
214,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
215,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
215,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
215,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
216,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
216,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
216,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
216,4,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
217,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
217,2,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
217,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
218,1,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
219,1,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
219,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
220,1,Localised oedema,Oedema NEC,General system disorders NEC,Genrl,N
220,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
221,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
221,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
222,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
223,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
224,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
225,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
226,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
227,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
227,2,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
227,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
227,4,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
227,5,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
227,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
228,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
228,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
229,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
230,1,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
230,2,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
230,3,Diabetic retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
230,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
231,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
231,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
232,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
233,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
233,2,Device failure,Device issues NEC,Device issues,Prod,N
234,1,Hypoglycaemia unawareness,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
235,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
236,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
237,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
238,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
238,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
239,1,Diabetic neuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
239,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
240,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
240,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
241,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
242,1,Device failure,Device issues NEC,Device issues,Prod,N
242,2,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
243,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
244,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
244,2,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
244,3,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
244,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
245,1,Spermatozoa abnormal,Fertility analyses and other reproductive function procedures,Reproductive organ and breast investigations (excl hormone analyses),Inv,N
246,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
247,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
248,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
248,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
249,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
249,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
249,3,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
250,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
251,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
252,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
253,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
253,2,Hypoglycaemia unawareness,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
253,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
254,1,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
255,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
255,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
256,1,Chronic fatigue syndrome,Asthenic conditions,General system disorders NEC,Genrl,N
257,1,Device leakage,Device issues NEC,Device issues,Prod,N
258,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
258,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
258,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
259,1,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
260,1,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
261,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
261,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
261,3,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
261,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
262,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
262,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
263,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
263,2,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
263,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
264,1,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
265,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
266,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
266,2,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
266,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
267,1,Device failure,Device issues NEC,Device issues,Prod,N
268,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
268,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
268,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
268,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
269,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
270,1,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
271,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
272,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
272,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
272,3,Depersonalisation/derealisation disorder,Dissociative states,Dissociative disorders,Psych,N
272,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
272,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
272,6,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
273,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
273,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
273,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
273,4,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
273,5,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
273,6,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
274,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
275,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
275,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
275,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
276,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
277,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
278,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
278,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
279,1,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
279,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
279,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
279,4,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
279,5,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
279,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
279,7,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
279,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
280,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
281,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
281,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
281,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
281,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
282,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
282,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
282,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
282,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
283,1,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
283,2,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
284,1,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
285,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
285,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
286,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
287,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
287,2,Device ineffective,Device issues NEC,Device issues,Prod,N
287,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
288,1,Headache,Headaches NEC,Headaches,Nerv,N
289,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
290,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
290,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
291,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
291,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
291,3,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
291,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
291,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
291,6,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
291,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
291,8,Headache,Headaches NEC,Headaches,Nerv,N
291,9,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
291,10,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
291,11,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
292,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
292,2,Device failure,Device issues NEC,Device issues,Prod,N
293,1,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
293,2,Bone lesion,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
293,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
293,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
294,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
294,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
295,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
296,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
296,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
296,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
296,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
296,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
297,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
297,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
297,3,Headache,Headaches NEC,Headaches,Nerv,N
297,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
298,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
298,2,Hypoglycaemia unawareness,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
299,1,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
300,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
301,1,Ketoacidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
302,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
302,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
302,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
302,4,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
303,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
304,1,Double outlet right ventricle,Great vessel disorders congenital,Cardiac and vascular disorders congenital,Cong,N
304,2,Gastrointestinal malformation,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
304,3,Multiple congenital abnormalities,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
304,4,Pulmonary valve stenosis congenital,Cardiac valve disorders congenital,Cardiac and vascular disorders congenital,Cong,N
304,5,Ventricular septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
305,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
305,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
305,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
305,4,Miliaria,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
305,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
305,6,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
305,7,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
306,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
307,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
307,2,Oedema mouth,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
307,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
307,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
308,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
308,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
308,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
308,4,Headache,Headaches NEC,Headaches,Nerv,N
308,5,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
309,1,Encephalocele,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
309,2,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
310,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
310,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
310,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
311,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
312,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
312,2,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
312,3,Dysmorphism,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
312,4,Finger deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
312,5,Low set ears,External ear disorders congenital,Ear and labyrinthine disorders congenital,Cong,N
312,6,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
313,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
314,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
314,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
315,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
315,2,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
315,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
316,1,Heart disease congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
317,1,Vulval cancer,Vulval neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
318,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
319,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
319,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
320,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
320,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
320,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
320,4,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
320,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
321,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
322,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
322,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
322,3,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
323,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
324,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
324,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
325,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
326,1,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
326,2,Retinal aneurysm,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
327,1,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
328,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
328,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
329,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
330,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
330,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
331,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
331,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
331,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
331,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
331,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
332,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
333,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
333,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
333,3,Headache,Headaches NEC,Headaches,Nerv,N
333,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
333,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
334,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
334,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
334,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
334,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
335,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
336,1,Hypoglycaemic coma,Coma states,Neurological disorders NEC,Nerv,N
336,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
336,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
337,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
337,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
337,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
337,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
338,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
339,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
339,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
340,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
340,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
340,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
341,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
341,2,Laryngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
342,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
342,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
342,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
342,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
343,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
343,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
344,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
345,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
346,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
347,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
347,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
348,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
349,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
349,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
350,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
351,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
351,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
352,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
352,2,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
353,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
354,1,Headache,Headaches NEC,Headaches,Nerv,N
355,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
356,1,Macular degeneration,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
357,1,Headache,Headaches NEC,Headaches,Nerv,N
358,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
358,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
359,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
359,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
360,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
361,1,Depersonalisation/derealisation disorder,Dissociative states,Dissociative disorders,Psych,N
361,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
362,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
363,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
364,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
364,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
364,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
364,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
364,5,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
365,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
365,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
365,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
366,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
366,2,Hypoglycaemia unawareness,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
366,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
367,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
367,2,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
368,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
368,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
368,3,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
368,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
369,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
369,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
370,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
370,2,Terminal state,General signs and symptoms NEC,General system disorders NEC,Genrl,N
371,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
372,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
372,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
372,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
372,4,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
372,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
372,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
372,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
373,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
373,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
373,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
374,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
374,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
374,3,Headache,Headaches NEC,Headaches,Nerv,N
374,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
374,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
374,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
374,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
375,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
376,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
377,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
377,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
377,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
377,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
377,5,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
378,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
378,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
378,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
378,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
379,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
379,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
379,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
380,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
380,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
380,3,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
380,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
380,5,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
380,6,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
380,7,Derealisation,Perception disturbances NEC,Disturbances in thinking and perception,Psych,N
380,8,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
380,9,Diabetic retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
380,10,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
380,11,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
380,12,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
380,13,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
380,14,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
380,15,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
380,16,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
380,17,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
380,18,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
380,19,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
380,20,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
381,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
381,2,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
381,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
381,4,Hypoglycaemic coma,Coma states,Neurological disorders NEC,Nerv,N
382,1,Acne,Acnes,Skin appendage conditions,Skin,N
382,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
383,1,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
384,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
385,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
385,2,Headache,Headaches NEC,Headaches,Nerv,N
385,3,Migraine,Migraine headaches,Headaches,Nerv,N
386,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
386,2,Clostridial infection,Clostridia infections,Bacterial infectious disorders,Infec,N
386,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
386,4,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
386,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
387,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
387,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
387,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
387,4,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
387,5,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
387,6,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
387,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
387,8,Odynophagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
387,9,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
387,10,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
388,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
388,2,Headache,Headaches NEC,Headaches,Nerv,N
389,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
390,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
390,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
391,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
391,2,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
391,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
392,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
392,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
392,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
393,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
393,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
393,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
393,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
394,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
395,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
395,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
396,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
396,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
397,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
398,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
398,2,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
398,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
398,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
399,1,Limb reduction defect,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
400,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
401,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
402,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
403,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
403,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
403,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
404,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
404,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
405,1,Hypoglycaemic coma,Coma states,Neurological disorders NEC,Nerv,N
405,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
406,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
406,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
407,1,Foetal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
407,2,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
407,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
407,4,Neonatal respiratory distress syndrome,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
407,5,Patent ductus arteriosus,Persistent foetal circulation disorders,Cardiac and vascular disorders congenital,Cong,N
407,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
408,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
408,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
408,3,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
408,4,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
408,5,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
409,1,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
410,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
411,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
411,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
411,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
411,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
411,5,Headache,Headaches NEC,Headaches,Nerv,N
411,6,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
411,7,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
411,8,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
412,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
413,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
413,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
413,3,Headache,Headaches NEC,Headaches,Nerv,N
413,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
413,5,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
413,6,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
413,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
413,8,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
414,1,Hypoglycaemic coma,Coma states,Neurological disorders NEC,Nerv,Y
415,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
416,1,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
416,2,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
417,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
418,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
419,1,Device failure,Device issues NEC,Device issues,Prod,N
420,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
421,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
421,2,Chronic fatigue syndrome,Asthenic conditions,General system disorders NEC,Genrl,N
421,3,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
421,4,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
421,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
421,6,Headache,Headaches NEC,Headaches,Nerv,N
421,7,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
421,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
422,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
422,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
422,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
423,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
423,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
424,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
424,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
424,3,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
425,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
426,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
427,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
428,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
428,2,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
429,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
429,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
429,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
429,4,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
429,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
429,6,Headache,Headaches NEC,Headaches,Nerv,N
429,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
430,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
430,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
430,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
430,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
430,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
430,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
430,7,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
431,1,Headache,Headaches NEC,Headaches,Nerv,N
432,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
432,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
433,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
434,1,Hypoglycaemic unconsciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
435,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
436,1,Hypoglycaemic seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
436,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
436,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
437,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
437,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
438,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
438,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
438,3,Pleurisy,Pleural infections and inflammations,Pleural disorders,Resp,N
438,4,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
439,1,Blood insulin increased,"Gastrointestinal, pancreatic and APUD hormone analyses",Endocrine investigations (incl sex hormones),Inv,N
439,2,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
440,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
440,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
441,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
442,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
442,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
442,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
443,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
443,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,Y
443,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
444,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
444,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
445,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
445,2,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
445,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
446,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
446,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
446,3,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
446,4,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
446,5,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
447,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
447,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
447,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
447,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
447,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
447,6,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
448,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
448,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
448,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
448,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
449,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
449,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
450,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
450,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
450,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
450,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
450,5,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
451,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
451,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
451,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
451,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
451,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
452,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
453,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
453,2,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
453,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
453,4,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
453,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
453,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
453,7,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
453,8,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
453,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
453,10,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
453,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
454,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
454,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
455,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
456,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
456,2,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
457,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
457,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
457,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
458,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
459,1,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,Y
459,2,Pulmonary malformation,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,N
459,3,Renal dysplasia,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
460,1,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
460,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
461,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
461,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
461,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
461,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
462,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
462,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
463,1,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
464,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
465,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
466,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
467,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
467,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
467,3,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
467,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
468,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
468,2,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
469,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
470,1,Papillitis,Inflammations,General system disorders NEC,Genrl,N
471,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
471,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
471,3,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
471,4,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
471,5,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
472,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
472,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
472,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
473,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
473,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
474,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
475,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
475,2,Bone disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
475,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
475,4,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
475,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
476,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
476,2,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
477,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
477,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
477,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
478,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
479,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
479,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
479,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
479,4,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
479,5,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
480,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
480,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
480,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
480,4,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
480,5,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
480,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
481,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
482,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
483,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
483,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
484,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
484,2,Hypoglycaemia unawareness,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
485,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
485,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
485,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
485,4,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
485,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
486,1,Hypoglycaemic unconsciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
486,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
486,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
487,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
487,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
487,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
487,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
487,5,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
487,6,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
488,1,Cardiac asthma,Heart failure signs and symptoms,Heart failures,Card,N
488,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
488,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
488,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
488,5,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
489,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
490,1,Premature rupture of membranes,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
490,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
491,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
491,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
492,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
492,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
492,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
492,4,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
492,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
493,1,Conductive deafness,Hearing losses,Hearing disorders,Ear,N
493,2,Jaundice neonatal,Neonatal hepatobiliary disorders,Neonatal and perinatal conditions,Preg,N
493,3,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
494,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
495,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
495,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
495,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
496,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
496,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
496,3,Headache,Headaches NEC,Headaches,Nerv,N
496,4,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
496,5,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
496,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
496,7,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
497,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
497,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
497,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
497,4,Hypoglycaemic unconsciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
498,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
498,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
498,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
499,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
500,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
500,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
500,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
501,1,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
501,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
502,1,Hypoglycaemic unconsciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
502,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
503,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
503,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
504,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
504,2,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
505,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
506,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
506,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
506,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
506,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
506,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
506,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
506,7,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
507,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
507,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
507,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
507,4,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
507,5,Hypoglycaemic unconsciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
507,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
507,7,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
507,8,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
507,9,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
508,1,Headache,Headaches NEC,Headaches,Nerv,N
509,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
509,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
509,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
509,4,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
510,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
510,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
510,3,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
510,4,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
510,5,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
510,6,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
510,7,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
510,8,Mallory-Weiss syndrome,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
510,9,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
510,10,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
510,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
510,12,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
511,1,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
511,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
511,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
512,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
512,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
512,3,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
512,4,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
512,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
512,6,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
513,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
513,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
513,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
513,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
514,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
515,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
515,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
515,3,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
515,4,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
515,5,Hypoglycaemic seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
515,6,Hypoglycaemic unconsciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
515,7,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
516,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
516,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
516,3,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
516,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
517,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
517,2,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
517,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
518,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
518,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
519,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
519,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
519,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
520,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
520,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
521,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
521,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
521,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
521,4,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
521,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
521,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
522,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
522,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
522,3,Ketoacidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
522,4,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
523,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
523,2,Headache,Headaches NEC,Headaches,Nerv,N
523,3,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
523,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
524,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
524,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
524,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
524,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
525,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
525,2,Therapeutic response increased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
526,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
527,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
527,2,Hypoglycaemic unconsciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
527,3,Hypoglycaemic unconsciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
527,4,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
528,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
528,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
528,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
528,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
529,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
529,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
530,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
530,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
530,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
531,1,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
531,2,Headache,Headaches NEC,Headaches,Nerv,N
531,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
531,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
531,5,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
532,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
532,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
532,3,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
533,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
533,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
534,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
535,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
536,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
536,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
536,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
536,4,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
536,5,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
536,6,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
536,7,Neuroendocrine tumour,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
537,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
537,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
537,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
537,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
538,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
539,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
539,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
540,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
541,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
541,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
541,3,Salivary hyposecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
542,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
542,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
543,1,Urine ketone body present,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
544,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
544,2,Diabetic neuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
544,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
545,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
545,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
546,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
547,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
547,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
547,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
548,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
549,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
549,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
549,3,Near death experience,Perception disturbances NEC,Disturbances in thinking and perception,Psych,N
549,4,Product counterfeit,"Counterfeit, falsified and substandard products","Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
550,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
550,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
550,3,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
550,4,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
550,5,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
551,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
551,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
551,3,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
551,4,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
551,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
551,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
552,1,Anti-insulin antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
552,2,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
552,3,Insulin resistance,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
552,4,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
553,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
554,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
555,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
555,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
555,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
555,4,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
555,5,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
555,6,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
555,7,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
555,8,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
555,9,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
555,10,Headache,Headaches NEC,Headaches,Nerv,N
555,11,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
555,12,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
555,13,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
555,14,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
555,15,Myalgia,Muscle pains,Muscle disorders,Musc,N
555,16,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
555,17,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
555,18,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
555,19,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
555,20,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
556,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
556,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
557,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
557,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
558,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
558,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
559,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
559,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
559,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
559,4,Hypoglycaemic unconsciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
560,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
560,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
561,1,Diabetic neuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
561,2,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
561,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
561,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
562,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
562,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
562,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
563,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
563,2,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
563,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
564,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
564,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
564,3,Injection site irritation,Injection site reactions,Administration site reactions,Genrl,N
564,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
564,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
565,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
566,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
566,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
567,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
568,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
568,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
569,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
569,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
569,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
569,4,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
569,5,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
570,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
570,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
570,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
571,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
571,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
571,3,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
572,1,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
572,2,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
572,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
573,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
573,2,Feeling jittery,Feelings and sensations NEC,General system disorders NEC,Genrl,N
573,3,Migraine,Migraine headaches,Headaches,Nerv,N
574,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
574,2,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
574,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
574,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
574,5,Hypoglycaemia unawareness,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
574,6,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
574,7,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
574,8,Myalgia,Muscle pains,Muscle disorders,Musc,N
574,9,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
575,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
576,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
576,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
576,3,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
576,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
576,5,Migraine,Migraine headaches,Headaches,Nerv,N
576,6,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
576,7,Myalgia,Muscle pains,Muscle disorders,Musc,N
577,1,Hypoglycaemic unconsciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
577,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
577,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
578,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
578,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
578,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
578,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
579,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
580,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
580,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
580,3,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
580,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
580,5,Costochondritis,Cartilage disorders,"Tendon, ligament and cartilage disorders",Musc,N
580,6,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
580,7,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
580,8,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
580,9,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
580,10,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
580,11,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
580,12,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
580,13,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
580,14,Iron deficiency anaemia,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
580,15,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
580,16,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
580,17,Pituitary tumour,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
580,18,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
580,19,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
581,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
581,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
581,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
581,4,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
582,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
582,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
583,1,Breast cancer in situ,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
584,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
585,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
585,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
585,3,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
586,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
587,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
588,1,Diabetic neuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
588,2,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
588,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
588,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
589,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
589,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
590,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
591,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
591,2,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
592,1,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
593,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
593,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
593,3,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
593,4,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
593,5,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
593,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
593,7,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
593,8,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
593,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
594,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
594,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
594,3,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
595,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
595,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
596,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
596,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
596,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
596,4,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
596,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
596,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
596,7,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
596,8,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
596,9,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
596,10,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
596,11,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
597,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
598,1,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
599,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
599,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
599,3,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
600,1,Pituitary tumour,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
601,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
601,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
601,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
601,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
601,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
602,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
602,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
602,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
602,4,Hypoglycaemia unawareness,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
602,5,Increased insulin requirement,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
602,6,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
603,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
603,2,Thymoma,Mediastinal neoplasms malignancy unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
604,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
605,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
606,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
606,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
607,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
608,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
608,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
608,3,Left ventricular failure,Left ventricular failures,Heart failures,Card,Y
608,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
609,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
609,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
609,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
609,4,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
609,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
609,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
609,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
609,8,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
609,9,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
609,10,Sleep attacks,Narcolepsy and associated conditions,Sleep disorders and disturbances,Psych,N
609,11,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
610,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
610,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
610,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
611,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
611,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
611,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
611,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
611,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
612,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
612,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
612,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
613,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
613,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
614,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
614,2,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
615,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
615,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
615,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
616,1,Chloropsia,Visual colour distortions,Vision disorders,Eye,N
616,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
617,1,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
617,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
617,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
617,4,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
617,5,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
617,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
618,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
618,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
618,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
618,4,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
618,5,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
618,6,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
619,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
620,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
620,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
620,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
621,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
621,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
622,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
622,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
623,1,Hypoglycaemic unconsciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
624,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
624,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
624,3,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
625,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
625,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
626,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
626,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
627,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
628,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
628,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
628,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
629,1,Ketoacidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
630,1,Lip and/or oral cavity cancer,Lip and oral cavity neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
631,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
631,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
632,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
633,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
633,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
634,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
635,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
635,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
635,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
636,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
636,2,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
636,3,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
637,1,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
637,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
637,3,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
637,4,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
638,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
638,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
638,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
639,1,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
639,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
640,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
640,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
640,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
640,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
641,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
641,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
641,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
642,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
643,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
643,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
643,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
644,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
644,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
644,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
644,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
645,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
646,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
646,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
647,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
647,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
647,3,Koebner phenomenon,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
647,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
648,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
648,2,Device breakage,Device physical property and chemical issues,Device issues,Prod,N
649,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
650,1,VACTERL syndrome,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
651,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
651,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
651,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
651,4,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
651,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
651,6,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
652,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
652,2,Body mass index decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
652,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
652,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
653,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
654,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
654,2,Device breakage,Device physical property and chemical issues,Device issues,Prod,N
654,3,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
654,4,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
655,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
656,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
656,2,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
656,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
656,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
657,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
657,2,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
657,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
658,1,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
658,2,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
658,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
659,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
660,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
660,2,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
661,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
661,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
662,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
662,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
662,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
663,1,Injection site papule,Injection site reactions,Administration site reactions,Genrl,N
663,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
664,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
665,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
665,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
665,3,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
665,4,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
665,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
665,6,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
666,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
666,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
666,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
666,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
667,1,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
667,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
667,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
668,1,Headache,Headaches NEC,Headaches,Nerv,N
668,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
668,3,Migraine,Migraine headaches,Headaches,Nerv,N
669,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
669,2,Device failure,Device issues NEC,Device issues,Prod,N
670,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
670,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
670,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
670,4,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
670,5,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
670,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
670,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
670,8,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
670,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
671,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
671,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
672,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
672,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
672,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
672,4,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
672,5,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
672,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
672,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
672,8,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
672,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
673,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
674,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
675,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
675,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
676,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
676,2,Product label confusion,Product confusion errors and issues,Medication errors and other product use errors and issues,Inj&P,N
677,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
677,2,Polyhydramnios,Amniotic fluid and cavity disorders of pregnancy NEC,"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
678,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
678,2,Polyhydramnios,Amniotic fluid and cavity disorders of pregnancy NEC,"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
679,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
679,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
680,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
681,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
681,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
681,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
682,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
682,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
683,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
684,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
684,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
684,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
685,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
685,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
685,3,Hypoglycaemic coma,Coma states,Neurological disorders NEC,Nerv,N
685,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
686,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
686,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
686,3,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
686,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
686,5,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
686,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
686,7,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
686,8,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
687,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
688,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
688,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
689,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
690,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
690,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
690,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
691,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
692,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
693,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
693,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
694,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
695,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
696,1,Hypoglycaemic coma,Coma states,Neurological disorders NEC,Nerv,N
697,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
698,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
698,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
698,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
698,4,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
698,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
698,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
698,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
699,1,Blood ketone body increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
699,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
699,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
700,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
700,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
700,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
700,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
701,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
701,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
701,3,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
701,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
701,5,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
701,6,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
701,7,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
701,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
701,9,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
702,1,Dyspnoea at rest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
703,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
704,1,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
704,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
704,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
704,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
705,1,Hypoglycaemic seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
706,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
706,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
707,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
707,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
708,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
708,2,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
709,1,Hypoglycaemic unconsciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
710,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
711,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
711,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
711,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
711,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
712,1,Ketoacidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
713,1,Hypoglycaemic unconsciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
714,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
715,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
715,2,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
716,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
717,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
717,2,Urine ketone body present,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
718,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
718,2,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
718,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
718,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
718,5,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
719,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
719,2,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
720,1,Onychoclasis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
721,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
722,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
722,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
723,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
723,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
724,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
724,2,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
725,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
725,2,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
725,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
726,1,Cataract subcapsular,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
726,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
727,1,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
727,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
727,3,Hypoglycaemic unconsciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
728,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
728,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
729,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
730,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
730,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
730,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
730,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
730,5,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
731,1,Hypoglycaemic seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
732,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
733,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
733,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
733,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
734,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,Y
734,2,Glycosylated haemoglobin abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
734,3,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
735,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
735,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
735,3,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
736,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
736,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
736,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
736,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
737,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,Y
738,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
738,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
738,3,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
738,4,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
738,5,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
739,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
739,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
739,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
740,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
741,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
742,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
743,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
744,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
744,2,Ketoacidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
744,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
745,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
745,2,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
746,1,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
747,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
747,2,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
747,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
747,4,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
748,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
748,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
748,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
748,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
749,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
749,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
749,3,Pancreatitis chronic,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
750,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
750,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
750,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
751,1,Hypoglycaemic seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
752,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
752,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
752,3,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
752,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
753,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
753,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
753,3,Seizure like phenomena,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
754,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
755,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
755,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
755,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
755,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
756,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
757,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
757,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
758,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
759,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
760,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
760,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
760,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
761,1,Headache,Headaches NEC,Headaches,Nerv,N
761,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
761,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
761,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
762,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
762,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
763,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
764,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
764,2,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
765,1,Device leakage,Device issues NEC,Device issues,Prod,N
765,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
766,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
767,1,Diabetic retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
768,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
769,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
769,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
769,3,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
769,4,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
769,5,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
769,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
769,7,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
770,1,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
771,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
771,2,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
771,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
772,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
773,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
773,2,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
773,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
773,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
774,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
775,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
775,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
775,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
776,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
776,2,Hypoglycaemic seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
776,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
777,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
778,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
778,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
778,3,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
779,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
779,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
780,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
780,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
780,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
781,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
781,2,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
781,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
781,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
782,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
782,2,Shock hypoglycaemic,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
783,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
783,2,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
783,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
783,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
784,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
784,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
784,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
785,1,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
786,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
786,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
787,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
787,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
787,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
788,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
788,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
788,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
788,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
788,5,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
788,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
789,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
789,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
790,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
790,2,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
791,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
791,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
791,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
791,4,Inflammation,Inflammations,General system disorders NEC,Genrl,N
791,5,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
792,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
793,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
793,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
793,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
794,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
794,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
795,1,Headache,Headaches NEC,Headaches,Nerv,N
795,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
795,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
795,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
796,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
796,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
796,3,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
797,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
797,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
797,3,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
797,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
797,5,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
797,6,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
797,7,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
797,8,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
797,9,Mean cell haemoglobin increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
797,10,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
797,11,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
797,12,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
797,13,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
797,14,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
797,15,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
798,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
798,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
799,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
800,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
800,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
801,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
801,2,Injection site hypersensitivity,Injection site reactions,Administration site reactions,Genrl,N
801,3,Injection site macule,Injection site reactions,Administration site reactions,Genrl,N
801,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
801,5,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
801,6,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
801,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
801,8,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
802,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
802,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
802,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
802,4,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
803,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
804,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
804,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
804,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
805,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
805,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
806,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
806,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
807,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
807,2,Diabetic neuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
807,3,Diabetic retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
807,4,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
807,5,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
808,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
808,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
808,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
809,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
810,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
811,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
812,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
812,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
813,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
814,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
814,2,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
814,3,Near death experience,Perception disturbances NEC,Disturbances in thinking and perception,Psych,N
814,4,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
815,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
816,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
816,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
816,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
817,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
817,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
818,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
818,2,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
819,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
819,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
819,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
820,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
820,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
820,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
821,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
822,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
823,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
823,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
824,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
825,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
825,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
826,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
826,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
827,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
827,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
828,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
828,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
828,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
828,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
828,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
828,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
829,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
829,2,Injection site hypersensitivity,Injection site reactions,Administration site reactions,Genrl,N
829,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
829,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
829,5,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
830,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
830,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
830,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
831,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
831,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
831,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
831,4,Injection site irritation,Injection site reactions,Administration site reactions,Genrl,N
831,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
831,6,Shock hypoglycaemic,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
831,7,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
832,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
832,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
832,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
832,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
832,5,Headache,Headaches NEC,Headaches,Nerv,N
832,6,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
832,7,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
832,8,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
832,9,Neuropathic arthropathy,Osteoarthropathies,Joint disorders,Musc,N
832,10,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
832,11,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
832,12,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
833,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
833,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
833,3,Hyporesponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
833,4,Listless,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
833,5,Wrong patient received product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
834,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
835,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
835,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
836,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
836,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
837,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
837,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
838,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
838,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
838,3,Therapeutic reaction time decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
839,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
839,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
839,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
839,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
840,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
840,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
840,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
841,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
841,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
842,1,Ketoacidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
843,1,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
843,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
843,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
844,1,Device issue,Device issues NEC,Device issues,Prod,N
844,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
845,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
845,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
845,3,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
845,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
845,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
845,6,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
845,7,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
845,8,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
845,9,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
845,10,Sudden hearing loss,Hearing losses,Hearing disorders,Ear,N
846,1,Abdominal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
846,2,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
846,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
846,4,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
846,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
847,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
847,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
847,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
847,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
847,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
847,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
848,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
849,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
850,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
850,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
851,1,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
852,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
852,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
852,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
852,4,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
852,5,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
852,6,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
853,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
853,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
854,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
854,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
855,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
856,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
856,2,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
856,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
857,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
857,2,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
858,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
858,2,Toe amputation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
858,3,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
859,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
859,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
860,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
860,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
860,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
861,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
862,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
863,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
863,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
864,1,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
864,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
864,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
865,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
866,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
866,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
866,3,Headache,Headaches NEC,Headaches,Nerv,N
866,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
866,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
866,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
866,7,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
867,1,Neuritis,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
867,2,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
868,1,Atrial septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
868,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
868,3,Hypoglycaemia neonatal,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
868,4,Jaundice neonatal,Neonatal hepatobiliary disorders,Neonatal and perinatal conditions,Preg,N
868,5,Neonatal respiratory distress syndrome,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
868,6,Polycythaemia neonatorum,Polycythaemia (excl rubra vera),Red blood cell disorders,Blood,N
869,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
870,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
870,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
870,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
870,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
870,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
870,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
871,1,Appetite disorder,Appetite disorders,Appetite and general nutritional disorders,Metab,N
871,2,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
871,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
872,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
872,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
872,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
873,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
873,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
874,1,Bone cancer,Bone neoplasms malignant (excl sarcomas),Skeletal neoplasms malignant and unspecified,Neopl,N
874,2,Hepatic cancer,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
874,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
874,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
875,1,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
875,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
875,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
875,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
875,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
875,6,Migraine,Migraine headaches,Headaches,Nerv,N
875,7,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
875,8,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
876,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
877,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
878,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
878,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
878,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
879,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
879,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
879,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
879,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
880,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
880,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
880,3,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
881,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
881,2,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
881,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
882,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
882,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
883,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
883,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
884,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
884,2,Hypoglycaemic unconsciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
885,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
886,1,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
887,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
888,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
889,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
890,1,Headache,Headaches NEC,Headaches,Nerv,N
890,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
890,3,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
890,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
891,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
892,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
892,2,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
893,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
893,2,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
893,3,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
894,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
894,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
894,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
895,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
896,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
896,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
897,1,Apraxia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
897,2,Atrophy,Trophic disorders,Tissue disorders NEC,Genrl,N
897,3,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
897,4,Dementia Alzheimer's type,Alzheimer's disease (incl subtypes),Mental impairment disorders,Nerv,N
897,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
897,6,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
897,7,Hypoglycaemic seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
897,8,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
898,1,Device issue,Device issues NEC,Device issues,Prod,N
898,2,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
898,3,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
898,4,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
898,5,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
899,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
900,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
901,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
901,2,Hyperglycaemic hyperosmolar nonketotic syndrome,Diabetic complications neurological,Diabetic complications,Metab,N
901,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
901,4,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
902,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
903,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
904,1,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
904,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
905,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
906,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
906,2,Laryngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
907,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
907,2,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
907,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
907,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
907,5,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
907,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
908,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
908,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
909,1,Headache,Headaches NEC,Headaches,Nerv,N
910,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
910,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
910,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
910,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
911,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
911,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
911,3,Steroid therapy,Hormonal therapeutic procedures NEC,Endocrine gland therapeutic procedures,Surg,N
912,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
912,2,Aortic valve stenosis,Aortic valvular disorders,Cardiac valve disorders,Card,N
912,3,Arteriosclerosis,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
912,4,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
913,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
913,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
913,3,Headache,Headaches NEC,Headaches,Nerv,N
913,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
913,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
914,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
914,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
915,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
916,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
917,1,Hypoglycaemic seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
917,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
917,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
917,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
918,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
918,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
918,3,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
919,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
919,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
920,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
920,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
920,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
920,4,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
920,5,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
920,6,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
921,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
922,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
923,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
924,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
924,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
924,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
925,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
926,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
927,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
927,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
928,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
928,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
929,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
929,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
929,3,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
929,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
929,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
929,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
930,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
930,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
930,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
930,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
930,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
931,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
931,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
931,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
931,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
932,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
932,2,Headache,Headaches NEC,Headaches,Nerv,N
932,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
933,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
933,2,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
933,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
934,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
934,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
934,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
934,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
934,5,Headache,Headaches NEC,Headaches,Nerv,N
934,6,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
934,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
934,8,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
934,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
934,10,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
934,11,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
935,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
936,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
936,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
936,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
936,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
936,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
936,6,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
936,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
936,8,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
936,9,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
936,10,Tongue discomfort,Tongue signs and symptoms,Tongue conditions,Gastr,N
936,11,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
937,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
937,2,Injection site irritation,Injection site reactions,Administration site reactions,Genrl,N
937,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
937,4,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
938,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
939,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
940,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
940,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
940,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
941,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
941,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
942,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
942,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
943,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
943,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
944,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
944,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
944,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
945,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
945,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
945,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
945,4,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
945,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
946,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
947,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
947,2,Headache,Headaches NEC,Headaches,Nerv,N
948,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
948,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
948,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
949,1,Atrial septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
949,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
949,3,Hypoglycaemia neonatal,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
949,4,Jaundice neonatal,Neonatal hepatobiliary disorders,Neonatal and perinatal conditions,Preg,N
949,5,Neonatal respiratory distress syndrome,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
949,6,Polycythaemia neonatorum,Polycythaemia (excl rubra vera),Red blood cell disorders,Blood,N
950,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
950,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
950,3,Headache,Headaches NEC,Headaches,Nerv,N
950,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
950,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
950,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
951,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
952,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
953,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
953,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
953,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
953,4,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
954,1,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
954,2,Ear pruritus,Ear disorders NEC,Aural disorders NEC,Ear,N
954,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
954,4,Tongue pruritus,Tongue signs and symptoms,Tongue conditions,Gastr,N
955,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
956,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
957,1,Toxic neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
957,2,Visual field defect,Visual field disorders,Vision disorders,Eye,N
958,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
958,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
958,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
958,4,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
959,1,Decreased insulin requirement,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
959,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
959,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
959,4,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
959,5,Foetal hypokinesia,Foetal complications NEC,Foetal complications,Preg,N
959,6,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
959,7,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
959,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
960,1,Caudal regression syndrome,Musculoskeletal and connective tissue disorders of spine congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
960,2,Congenital bladder anomaly,Bladder disorders congenital,Renal and urinary tract disorders congenital,Cong,N
960,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
960,4,Gastrointestinal malformation,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
960,5,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
960,6,Perineal ulceration,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
960,7,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
961,1,Anti-insulin antibody,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
961,2,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
961,3,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
961,4,Injection site hypersensitivity,Injection site reactions,Administration site reactions,Genrl,N
961,5,Insulin resistance,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
961,6,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
961,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
962,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
962,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
962,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
963,1,Drug administered in wrong device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
963,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
963,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
963,4,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
963,5,Near death experience,Perception disturbances NEC,Disturbances in thinking and perception,Psych,N
963,6,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
964,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
964,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
965,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
966,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
966,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
966,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
967,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
967,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
967,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
968,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
968,2,Chronic lymphocytic leukaemia,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
968,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
968,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
968,5,Feeling drunk,Feelings and sensations NEC,General system disorders NEC,Genrl,N
968,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
968,7,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
968,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
968,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
968,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
968,11,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
968,12,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
968,13,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
968,14,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
969,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
969,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
969,3,Borderline mucinous tumour of ovary,Female reproductive neoplasms unspecified malignancy,Reproductive neoplasms female malignant and unspecified,Neopl,N
969,4,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
969,5,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
969,6,Inflammation,Inflammations,General system disorders NEC,Genrl,N
969,7,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
969,8,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
969,9,Ovarian cyst,Ovarian and fallopian tube cysts and neoplasms,Ovarian and fallopian tube disorders,Repro,N
969,10,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
970,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
970,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
970,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
970,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
971,1,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
972,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
972,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
972,3,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
972,4,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
973,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
974,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
974,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
974,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
974,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
975,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
976,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
977,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
978,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
979,1,Blood ketone body present,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
979,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
979,3,Foetal renal imaging abnormal,Foetal and neonatal imaging procedures,Foetal and neonatal investigations,Inv,N
979,4,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
979,5,Vacuum extractor delivery,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
980,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
980,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
981,1,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
981,2,Myopathy,Myopathies,Muscle disorders,Musc,N
982,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
983,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
983,2,Hyperaesthesia teeth,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
983,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
983,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
983,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
983,6,Palatal swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
984,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
984,2,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
984,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
984,4,Gingival swelling,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
984,5,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
984,6,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
984,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
985,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
986,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
986,2,Hypoglycaemia neonatal,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
986,3,Neonatal respiratory distress syndrome,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
986,4,Sepsis neonatal,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
987,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
987,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
988,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
988,2,Foetal hypokinesia,Foetal complications NEC,Foetal complications,Preg,N
988,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
989,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
990,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
991,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
991,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
991,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
992,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
993,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
993,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
993,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
993,4,Lipohypertrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
994,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
994,2,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
994,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
994,4,Device use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
994,5,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
995,1,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
996,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
996,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
996,3,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
996,4,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
996,5,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
996,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
996,7,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
997,1,Drug administered in wrong device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
997,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
997,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
998,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
998,2,Cardiac asthma,Heart failure signs and symptoms,Heart failures,Card,N
998,3,Migraine,Migraine headaches,Headaches,Nerv,N
999,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1000,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
1000,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1000,3,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1001,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1001,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1002,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1002,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
1002,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1003,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1003,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1003,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1004,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1004,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1004,3,Muscle strain,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
1004,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1005,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1006,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1006,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1006,3,Formication,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1006,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1006,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1006,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1006,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1006,8,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1006,9,Suicidal behaviour,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1006,10,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1007,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1008,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1008,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1009,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1009,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1009,3,Uterine polyp,Uterine neoplasms,"Uterine, pelvic and broad ligament disorders",Repro,N
1009,4,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1010,1,Angiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1010,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1010,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1010,4,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1011,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1011,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1011,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1012,1,Decreased insulin requirement,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1012,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1012,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1012,4,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1012,5,Foetal hypokinesia,Foetal complications NEC,Foetal complications,Preg,N
1012,6,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1012,7,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1012,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1013,1,Hypoglycaemia unawareness,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1013,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1014,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1015,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1015,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1015,3,Steroid therapy,Hormonal therapeutic procedures NEC,Endocrine gland therapeutic procedures,Surg,N
1016,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1017,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1018,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1018,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1019,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1020,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1020,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1021,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1021,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1022,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1023,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
1023,2,Eyelid disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
1024,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1024,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1024,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1025,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1026,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1026,2,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1026,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1027,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1028,1,Lower respiratory tract infection viral,Viral infections NEC,Viral infectious disorders,Infec,N
1028,2,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1029,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1029,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1030,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1030,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1031,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1031,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1031,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1031,4,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
1031,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1031,6,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1031,7,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1032,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1033,1,Administration site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1033,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
1033,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1033,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1034,1,Hepatic cancer,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
1035,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1035,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1036,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1036,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1036,3,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1036,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1036,5,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1036,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1036,7,Hyperglycaemic hyperosmolar nonketotic syndrome,Diabetic complications neurological,Diabetic complications,Metab,N
1036,8,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1036,9,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1037,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1038,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1039,1,Acetonaemia,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1039,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1039,3,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1039,4,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1039,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1039,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1040,1,Abdominal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1040,2,Abscess intestinal,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1040,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1040,4,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1040,5,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
1040,6,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1040,7,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1041,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1042,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1042,2,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1043,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1044,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1044,2,Prescription drug used without a prescription,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1045,1,Angiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1045,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1046,1,Congenital bladder anomaly,Bladder disorders congenital,Renal and urinary tract disorders congenital,Cong,N
1046,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1046,3,Foetal hypokinesia,Foetal complications NEC,Foetal complications,Preg,N
1046,4,Genitalia external ambiguous,Reproductive tract disorders congenital NEC,Reproductive tract and breast disorders congenital,Cong,N
1046,5,Neonatal respiratory depression,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
1047,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1047,2,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1047,3,Inguinal hernia,Inguinal hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
1047,4,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
1048,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1049,1,Arrhythmia neonatal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1049,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1049,3,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
1049,4,Jaundice neonatal,Neonatal hepatobiliary disorders,Neonatal and perinatal conditions,Preg,N
1049,5,Necrotising enterocolitis neonatal,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
1049,6,Neonatal respiratory distress syndrome,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
1049,7,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1050,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1050,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1050,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1050,4,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1051,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1051,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1051,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1051,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1052,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1052,2,Near death experience,Perception disturbances NEC,Disturbances in thinking and perception,Psych,N
1052,3,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1052,4,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1053,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1053,2,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
1053,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1054,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1054,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1054,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1055,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
1055,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1056,1,Apgar score abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1056,2,Congenital scoliosis,Musculoskeletal and connective tissue disorders of spine congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
1056,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1056,4,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1056,5,Neonatal respiratory distress syndrome,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
1057,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1057,2,Neonatal respiratory distress syndrome,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
1057,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1058,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
1058,2,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1058,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1059,1,Amniotic cavity infection,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
1059,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1059,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1059,4,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1060,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1060,2,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
1060,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1061,1,Apgar score abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1061,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1061,3,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1061,4,Neonatal respiratory distress syndrome,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
1061,5,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1061,6,Underweight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1062,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
1062,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1063,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1063,2,Cholestasis of pregnancy,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1063,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1064,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
1064,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1065,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1065,2,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
1065,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1066,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1066,2,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
1066,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1067,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1067,2,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
1067,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1068,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1068,2,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
1068,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1069,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1069,2,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
1069,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1070,1,Congenital pneumonia,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,N
1070,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1070,3,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1071,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
1071,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1071,3,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1071,4,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1072,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1072,2,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
1072,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1073,1,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
1073,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1073,3,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1074,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1074,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1074,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1075,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1075,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1075,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1076,1,Hypoglycaemic unconsciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1076,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1077,1,Accidental underdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1077,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1077,3,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1077,4,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1077,5,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1077,6,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1077,7,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1078,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1078,2,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
1079,1,Device operational issue,Device operational issues NEC,Device issues,Prod,N
1079,2,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1079,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1080,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1081,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1081,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1082,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1083,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1084,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1085,1,Device operational issue,Device operational issues NEC,Device issues,Prod,N
1085,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1086,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1086,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1087,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1087,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1088,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1088,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1089,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1089,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1090,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1090,2,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
1090,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1091,1,Headache,Headaches NEC,Headaches,Nerv,N
1091,2,Headache,Headaches NEC,Headaches,Nerv,N
1091,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1091,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1092,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1092,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1092,3,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1093,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1093,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1094,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1094,2,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1095,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1095,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1095,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1096,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1096,2,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1096,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1096,4,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1097,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1097,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1098,1,Diabetic retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1098,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1099,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1099,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1099,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1099,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1100,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1100,2,Drug dispensed to wrong patient,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1101,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1101,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1102,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1103,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
1104,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1104,2,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1104,3,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
1104,4,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1104,5,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
1104,6,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1105,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1105,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1105,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1106,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1106,2,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1106,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1106,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1107,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1107,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1107,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1108,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1108,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1108,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1109,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1109,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1109,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1110,1,Ichthyosis,Skin and subcutaneous tissue disorders congenital NEC,Skin and subcutaneous tissue disorders congenital,Cong,N
1110,2,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
1110,3,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
1110,4,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
1110,5,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1111,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1111,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1112,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1112,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1112,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1112,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1113,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1114,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1114,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1115,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1115,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1116,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1117,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1117,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1117,3,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1117,4,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
1117,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1117,6,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1118,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1118,2,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1119,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1120,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
1121,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1121,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1121,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1122,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
1123,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1123,2,Device issue,Device issues NEC,Device issues,Prod,N
1123,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1123,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1123,5,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1123,6,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1123,7,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1124,1,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1124,2,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1125,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1125,2,Injection site hypersensitivity,Injection site reactions,Administration site reactions,Genrl,N
1126,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1127,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1127,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1128,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1129,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1130,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1131,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1131,2,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
1132,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1132,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1133,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1133,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1133,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1134,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1135,1,Device breakage,Device physical property and chemical issues,Device issues,Prod,N
1135,2,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1136,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1136,2,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1136,3,Suspected product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1137,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1137,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
1137,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1138,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1139,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1139,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1139,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1140,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1140,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1140,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1140,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1140,5,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1141,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1142,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1143,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1143,2,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
1144,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1145,1,Accidental underdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1145,2,Diabetic eye disease,Ocular disorders NEC,Eye disorders NEC,Eye,N
1146,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1146,2,Cardiogenic shock,Heart failures NEC,Heart failures,Card,N
1146,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1146,4,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1146,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1146,6,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1146,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1146,8,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1146,9,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1147,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1148,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1149,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1149,2,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1150,1,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
1151,1,Hypoglycaemia unawareness,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1151,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1152,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1152,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1152,3,Product preparation error,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1152,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1153,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1154,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1155,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1155,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1156,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1156,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1156,3,Urine ketone body present,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
1156,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1157,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1158,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1159,1,Nasal polyps,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1160,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1160,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1160,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1161,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1161,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1161,3,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,Y
1162,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1162,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1163,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1164,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1164,2,Hypoglycaemia neonatal,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1165,1,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1165,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1165,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1165,4,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1166,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1166,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1167,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1167,2,Injection site irritation,Injection site reactions,Administration site reactions,Genrl,N
1167,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1168,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1168,2,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1169,1,Device mechanical issue,Device physical property and chemical issues,Device issues,Prod,N
1169,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1170,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1170,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1170,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1170,4,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1171,1,Device issue,Device issues NEC,Device issues,Prod,N
1171,2,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1172,1,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1172,2,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
1173,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1174,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1175,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1175,2,Hypoglycaemia neonatal,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1175,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1176,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1177,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1178,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1178,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1178,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1179,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1179,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1179,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1180,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1180,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1180,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1181,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1181,2,Lack of injection site rotation,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1182,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1182,2,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1183,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1184,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1185,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1185,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1185,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1185,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1186,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1187,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1188,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1188,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1188,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1189,1,Headache,Headaches NEC,Headaches,Nerv,N
1190,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1191,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1192,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1192,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1193,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1193,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1193,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1193,4,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1194,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1195,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1195,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1196,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1196,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1196,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1197,1,Device issue,Device issues NEC,Device issues,Prod,N
1197,2,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1198,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
1198,2,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
1199,1,Cervical vertebral fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
1200,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1200,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1200,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1201,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1202,1,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
1203,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1204,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1204,2,Headache,Headaches NEC,Headaches,Nerv,N
1205,1,Daydreaming,Cognitive and attention disorders and disturbances NEC,Cognitive and attention disorders and disturbances,Psych,N
1205,2,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1206,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1206,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1206,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1206,4,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1206,5,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1206,6,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1206,7,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1206,8,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1206,9,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1206,10,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1206,11,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1206,12,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1206,13,Headache,Headaches NEC,Headaches,Nerv,N
1206,14,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1206,15,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1206,16,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1206,17,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1206,18,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1207,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1207,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1207,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1208,1,Device issue,Device issues NEC,Device issues,Prod,N
1208,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1208,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1209,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1209,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1209,3,Oropharyngeal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1209,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1210,1,Device operational issue,Device operational issues NEC,Device issues,Prod,N
1210,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1210,3,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1211,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1211,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1211,3,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1212,1,Carbon dioxide increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1212,2,Disability,Disability issues,Lifestyle issues,SocCi,N
1213,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1213,2,Device delivery system issue,Device issues NEC,Device issues,Prod,N
1213,3,Device issue,Device issues NEC,Device issues,Prod,N
1214,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1214,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1215,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1216,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1217,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
1217,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1217,3,Dysgraphia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1217,4,Frustration tolerance decreased,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1217,5,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1217,6,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1218,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1219,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1220,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1220,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1220,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1221,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1221,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1221,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1222,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1222,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1222,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1223,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1223,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1223,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1223,4,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1223,5,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1223,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1224,1,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
1225,1,Device ineffective,Device issues NEC,Device issues,Prod,N
1226,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1226,2,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1226,3,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
1226,4,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
1227,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
1227,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1228,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1228,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1229,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1230,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1230,2,Device delivery system issue,Device issues NEC,Device issues,Prod,N
1230,3,Device leakage,Device issues NEC,Device issues,Prod,N
1231,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1231,2,Device issue,Device issues NEC,Device issues,Prod,N
1231,3,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1232,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1232,2,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
1232,3,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1233,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1233,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1234,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1234,2,Device leakage,Device issues NEC,Device issues,Prod,N
1234,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1235,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1235,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1235,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1236,1,Device operational issue,Device operational issues NEC,Device issues,Prod,N
1236,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1236,3,Headache,Headaches NEC,Headaches,Nerv,N
1237,1,Cutaneous amyloidosis,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1237,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1238,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
1239,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1240,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1240,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1240,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1240,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1240,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1240,6,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1241,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1241,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1241,3,Thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
1242,1,Headache,Headaches NEC,Headaches,Nerv,N
1243,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1243,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1243,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1243,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1244,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1244,2,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1245,1,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1246,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1247,1,Headache,Headaches NEC,Headaches,Nerv,N
1248,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1248,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1248,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1249,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1249,2,Device issue,Device issues NEC,Device issues,Prod,N
1249,3,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1249,4,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1249,5,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1249,6,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1250,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1250,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1250,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1251,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1252,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1253,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1254,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1254,2,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
1254,3,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1255,1,Mite allergy,Allergic conditions NEC,Allergic conditions,Immun,N
1255,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1256,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1256,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1257,1,Product dispensing issue,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1258,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1258,2,Spinal deformity,Spine and neck deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
1259,1,Headache,Headaches NEC,Headaches,Nerv,N
1260,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1260,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1260,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1260,4,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1261,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1262,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1262,2,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1262,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1262,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1262,5,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1262,6,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1262,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1262,8,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1262,9,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1262,10,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1263,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1263,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1263,3,Therapeutic product effect prolonged,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1264,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1264,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1265,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1265,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1266,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1266,2,Wrong device used,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1267,1,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1267,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1268,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1269,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1269,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1270,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1270,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1270,3,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1271,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1271,2,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
1272,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1272,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1272,3,Lipohypertrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
1272,4,Off label use of device,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1273,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1273,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1273,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1273,4,Suspected product contamination,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1273,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1273,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1274,1,Device issue,Device issues NEC,Device issues,Prod,N
1274,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1275,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1275,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1276,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1276,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1276,3,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1276,4,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1277,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1277,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1278,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1279,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1280,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1280,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1281,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1282,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1283,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1284,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1284,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1284,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1285,1,Acanthosis nigricans,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
1285,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1285,3,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
1286,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1286,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1287,1,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
1288,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1288,2,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1289,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1289,2,Seasonal allergy,Atopic disorders,Allergic conditions,Immun,N
1290,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1290,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1290,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1291,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1292,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1293,1,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1294,1,Drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1294,2,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
1294,3,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1295,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1295,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1296,1,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1297,1,Headache,Headaches NEC,Headaches,Nerv,N
1297,2,Migraine,Migraine headaches,Headaches,Nerv,N
1297,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1298,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1298,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1299,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
1299,2,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
1299,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1299,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1299,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1299,6,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1300,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1300,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1300,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1300,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1300,5,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1300,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1301,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1301,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1301,3,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1301,4,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1301,5,Blood ketone body present,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
1301,6,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1301,7,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1301,8,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1301,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1301,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1301,11,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1301,12,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1302,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1303,1,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1304,1,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1304,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1305,1,Device mechanical issue,Device physical property and chemical issues,Device issues,Prod,N
1305,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1306,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1306,2,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1307,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1308,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
1309,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1310,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
1311,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1311,2,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1312,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1312,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1312,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1312,4,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1312,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1313,1,Bone marrow oedema syndrome,Haematological disorders,Haematological disorders NEC,Blood,N
1313,2,Femoral neck fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1313,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1314,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
1315,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
1316,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1316,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1316,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1316,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1317,1,Headache,Headaches NEC,Headaches,Nerv,N
1318,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1319,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1320,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1320,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1321,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1322,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1322,2,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1323,1,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1324,1,Arthropod sting,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1325,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1325,2,Gastrointestinal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1325,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1326,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1326,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1326,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1326,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1326,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1327,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1328,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1329,1,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1329,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1330,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1331,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1331,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1331,3,Dawn phenomenon,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1331,4,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1332,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1332,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1333,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1333,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1334,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1335,1,Craniocerebral injury,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1335,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1336,1,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1337,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1338,1,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1338,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1339,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1340,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1341,1,Device mechanical issue,Device physical property and chemical issues,Device issues,Prod,N
1341,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1341,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1342,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1343,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1343,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1343,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1343,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1344,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1344,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1344,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1344,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1345,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
1346,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1347,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1347,2,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1348,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1348,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1349,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1350,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1351,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1351,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1352,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1353,1,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1353,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1353,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1353,4,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1353,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1354,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1355,1,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1355,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1355,3,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1355,4,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1355,5,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1356,1,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1356,2,Dyslexia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1356,3,Intercepted product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
1357,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1358,1,Anti-insulin antibody,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
1358,2,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1358,3,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1358,4,Hyperinsulinaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1358,5,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1358,6,Insulin resistance,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1359,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1359,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
1359,3,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1359,4,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1359,5,Insulin resistance,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1360,1,Anti-insulin antibody,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
1360,2,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1360,3,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1360,4,Insulin resistance,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1361,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1362,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1363,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1364,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1364,2,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
1365,1,Device breakage,Device physical property and chemical issues,Device issues,Prod,N
1365,2,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1365,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1366,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1367,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1367,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1368,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1368,2,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1369,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
1370,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1371,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1371,2,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1372,1,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1373,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1373,2,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1373,3,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1374,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1374,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1375,1,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1376,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1377,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1377,2,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1377,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1378,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1379,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1379,2,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1379,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1379,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1380,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1380,2,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1380,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1380,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1380,5,Upper motor neurone lesion,Motor neurone diseases,Neuromuscular disorders,Nerv,N
1381,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1381,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1382,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1382,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1383,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1383,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1383,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1383,4,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
1384,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1384,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1385,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1385,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1386,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1386,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1387,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1387,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1388,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1388,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1388,3,Tonsillar hypertrophy,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1389,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1390,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1390,2,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
1391,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1391,2,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1391,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1391,4,Weight gain poor,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1392,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1393,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1393,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1394,1,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1394,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1395,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1395,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1396,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1396,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1396,3,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1396,4,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1397,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
1398,1,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1399,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1399,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1399,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1399,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1399,5,Headache,Headaches NEC,Headaches,Nerv,N
1400,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1401,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1401,2,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
1402,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1402,2,Device breakage,Device physical property and chemical issues,Device issues,Prod,N
1402,3,Device calibration failure,Device issues NEC,Device issues,Prod,N
1403,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1403,2,Device calibration failure,Device issues NEC,Device issues,Prod,N
1404,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1405,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1406,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1407,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1408,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1408,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1409,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1409,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1410,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
1411,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1412,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1412,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1412,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1412,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1412,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1413,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1413,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1413,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1413,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1413,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1414,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1414,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1414,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1414,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1415,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1415,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1416,1,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
1417,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1417,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1418,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1419,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1420,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
